Novo Nordisk A/S Common Stock (NVO) R&D Expense Growth & History | Stock Alarm

Demo Sign up Log In

Novo Nordisk A/S Common Stock · R&D Expense Growth

NVO R&D Expense Growth

Latest reported8.27%period endingDec 31, 2025

NVO FY R&D Growth (YoY) (0.00% → 8.27%)

Latest values, visible window

High-resolution chart · PNG

NVO r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock R&D Expense Growth — Annual fiscal periods
Period ending	R&D Expense Growth
Dec 31, 2025	8.2747%
Dec 31, 2024	48.1429%
Dec 31, 2023	34.915%
Dec 31, 2022	35.3084%
Dec 31, 2021	14.9399%
Dec 31, 2020	8.7342%
Dec 31, 2019	-3.9514%
Dec 31, 2018	5.6444%
Dec 31, 2017	-3.7698%
Dec 31, 2016	7.0179%
Dec 31, 2015	-1.119%
Dec 31, 2014	17.2931%
Dec 31, 2013	7.6718%
Dec 31, 2012	13.1803%
Dec 31, 2011	0.2708%
Dec 31, 2010	22.1007%
Dec 31, 2009	-0.1273%
Dec 31, 2008	-7.9127%
Dec 31, 2007	35.3507%
Dec 31, 2006	24.4875%
Dec 31, 2005	15.735%
Dec 31, 2004	4.3015%
Dec 31, 2003	1.7071%
Dec 31, 2002	4.3833%
Dec 31, 2001	22.8027%
Dec 31, 2000	24.6166%
Dec 31, 1999	-2.3385%
Dec 31, 1998	-4.3366%
Dec 31, 1997	0%
Dec 31, 1996	0%
Dec 31, 1995	0%
Dec 31, 1994	0%
Dec 31, 1993	0%
Dec 31, 1992	0%
Dec 31, 1991	0%
Dec 31, 1990	0%
Dec 31, 1989	0%
Dec 31, 1988	0%
Dec 31, 1987	0%
Dec 31, 1986	0%
Dec 31, 1985	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.